Krystal Biotech Income Statement (2016-2026) | KRYS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
8.56M42.14M45.25M70.30M83.84M91.14M88.18M96.04M97.80M107.11M116.40M119.22M
Cost of Revenue (Quarter)
0.22M2.87M2.42M6.01M6.68M4.95M5.03M7.17M4.26M6.59M6.32M6.44M
Gross Profit (Quarter)
8.33M39.27M42.83M64.29M77.16M86.19M83.16M88.88M93.54M100.51M110.08M112.78M
Operating items
Research & Development (Quarter)
6.08M9.01M9.31M10.89M11.52M10.74M12.29M12.14M10.63M11.37M10.96M15.58M13.51M13.53M14.26M14.41M14.59M14.79M15.33M14.52M
Selling, General & Administrative (Quarter)
9.57M12.87M15.91M17.86M19.93M24.03M24.04M25.90M23.70M24.65M26.06M27.63M28.67M31.29M32.65M35.16M37.58M41.45M41.01M39.85M
Restructuring Costs (Quarter)
25.00M12.50M12.50M37.50M37.50M37.50M12.50M
Other Operating Expenses (Quarter)
-12.50M100.00M-22.58M-18.99M5.03M7.17M4.26M6.59M6.32M6.44M
Operating Expenses (Quarter)
15.65M21.88M50.22M28.75M31.45M34.77M48.82M38.05M34.55M38.90M51.93M61.72M61.37M49.76M51.93M56.73M56.43M62.84M62.67M60.80M
Operating Income (Quarter)
-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M58.42M
EBIT (Quarter)
-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M58.42M
Non-operating items
Interest & Investment Income (Quarter)
0.01M-0.15M-1.03M-0.35M0.07M0.75M0.57M-0.08M-0.15M1.09M-0.88M-0.25M1.84M-1.15M0.34M-0.16M0.66M-0.20M-1.58M-1.21M
Non Operating Income (Quarter)
6.74M7.41M7.62M7.48M7.30M7.24M7.34M7.47M6.59M6.86M7.75M7.66M
Net income details
EBT (Quarter)
-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M10.66M0.93M16.05M29.77M48.61M43.60M46.77M47.97M51.13M61.44M66.08M
Tax Provisions (Quarter)
1.97M0.48M2.60M3.13M7.86M8.40M-31.40M-0.26M5.50M11.31M
Profit After Tax (Quarter)
-15.59M-21.95M-49.97M-28.11M-29.78M-32.05M-45.30M-33.21M80.60M8.35M0.93M15.57M29.33M45.48M36.31M38.33M79.36M51.40M55.93M54.77M
Income from Continuing Operations (Quarter)
-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M54.77M
Consolidated Net Income (Quarter)
-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M54.77M
Income towards Parent Company (Quarter)
-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M54.77M
Net Income towards Common Stockholders (Quarter)
-25.10M-22.02M-81.62M-57.44M-68.59M-34.02M-114.31M-33.21M80.75M8.69M0.93M15.57M27.17M45.48M35.73M38.38M79.36M51.39M55.94M54.77M
Additional items
EPS (Basic) (Quarter)
-1.13-0.99-3.25-2.25-2.68-1.33-4.45-1.252.880.320.030.540.951.591.241.332.741.781.911.85
EPS (Diluted) (Quarter)
-1.13-0.99-3.25-2.25-2.68-1.33-4.45-1.252.790.310.030.530.911.531.201.292.661.721.831.79
Shares Outstanding (Quarter)
22.21M22.20M25.11M25.55M25.62M25.49M25.71M26.66M28.04M27.15M28.30M28.60M28.72M28.59M28.82M28.91M28.95M28.94M29.29M29.53M
Shares Outstanding (Diluted) (Quarter)
22.21M22.20M25.11M25.55M25.62M25.49M25.71M26.66M28.89M27.75M29.29M29.64M29.90M29.74M29.87M29.75M29.83M29.95M30.51M30.66M
Shares Outstanding (Entity) (Quarter)
22.24M25.21M25.20M25.66M25.71M25.76M25.80M27.97M28.19M28.24M28.53M28.71M28.76M28.79M28.90M28.93M28.98M29.19M29.44M29.60M
EBITDA (Quarter)
-15.65M-21.88M-50.22M-28.75M-31.45M-34.77M-48.82M-38.05M-25.99M3.25M-6.68M8.57M22.47M41.38M36.25M39.31M41.37M44.27M53.69M58.42M
Interest Expenses (Quarter)
9.46M30.36M28.34M37.21M66.07M169.12M133.65M150.41M236.28M219.58M209.85M156.40M198.81M117.14M180.42M298.66M286.11M475.42M
Tax Rate (Quarter)
18.44%2.97%8.73%6.44%18.04%17.96%-65.46%-0.51%8.95%17.12%